Skip to main content
. 2017 Dec 18;7:17705. doi: 10.1038/s41598-017-17672-9

Figure 4.

Figure 4

Compounds identified by in silico screening inhibit IMPα/β1:C binding. Pre-dimerized recombinant IMPα/β1 heterodimer (15 nM) and capsid (30 nM) were incubated together in the presence of 10 µM of each compound, and protein binding measured by AlphaScreen assay as described in Materials and Methods. The percentage inhibition of binding effected by each compound above background was standardized to DMSO-only positive control wells. Histogram shows the distribution of activity of all 84 compounds tested.